1,170
Views
77
CrossRef citations to date
0
Altmetric
Review Article

Neuroinflammation in suicide: Toward a comprehensive model

, , , , &
Pages 564-586 | Received 30 Jan 2015, Accepted 20 May 2015, Published online: 30 Jul 2015

References

  • Aliberti J, Bafica A. 2005. Anti-inflammatory pathways as a host evasion mechanism for pathogens. Prostaglandins Leukot Essent Fatty Acids 73:283–288.
  • Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. 2009. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197:905–908.
  • Artero S, Astruc B, Courtet P, Ritchie K. 2006. Life-time history of suicide attempts and coronary artery disease in a community-dwelling elderly population. Int J Geriatr Psychiatry 21: 108–112.
  • Asano NM, Coriolano M, Asano BJ, Lins OG. 2013. Psychiatric comorbidities in patients with systemic lupus erythematosus: a systematic review of the last 10 years. Rev Bras Reumatol 53:431–437.
  • Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, et al. 2014. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 58:161–166.
  • Baron DA, Hardie T, Baron SH. 1993. Possible association of interleukin-2 treatment with depression and suicide. J Am Osteopath Assoc 93:799–800.
  • Baumeister RF, Leary MR. 1995. The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychol Bull 117:497–529.
  • Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L, Guillemin GJ, et al. 2015. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain Behav Immun 43:110–117.
  • Bayard-Burfield L, Alling C, Blennow K, Jonsson S, Traskman-Bendz L. 1996. Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 6:195–199.
  • Bergen H, Hawton K, Waters K, Ness J, Cooper J, Steeg S, et al. 2012. Premature death after self-harm: a multicentre cohort study. Lancet 380:1568–1574.
  • Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. 2000. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354.
  • Black C, Miller BJ. 2014. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 78:28–37.
  • Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N. 2005. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1457–1459.
  • Bryant PA, Trinder J, Curtis N. 2004. Sick and tired: Does sleep have a vital role in the immune system? Nat Rev Immunol 4:457–467.
  • Cacioppo JT, Hawkley LC. 2003. Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med 46, S39–52.
  • Cacioppo JT, Hawkley LC, Crawford LE, Ernst JM, Burleson MH, Kowalewski RB, et al. 2002. Loneliness and health: potential mechanisms. Psychosom Med 64:407–417.
  • Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, et al. 2005. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58:190–196.
  • Carlborg A, Jokinen J, Jonsson EG, Erhardt S, Nordstrom P. 2013. CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis. Psychiatry Res 205:165–167.
  • Carroll JE, Low CA, Prather AA, Cohen S, Fury JM, Ross DC, et al. 2011. Negative affective responses to a speech task predict changes in interleukin (IL)-6. Brain Behav Immun 25:232–238.
  • Christodoulou C, Douzenis A, Papadopoulos FC, Papadopoulou A, Bouras G, Gournellis R, et al. 2012. Suicide and seasonality. Acta Psychiatr Scand 125:127–146.
  • Cipriani A, Hawton K, Stockton S, Geddes JR. 2013. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. Br Med J 346:f3646.
  • Coccaro EF, Lee R, Coussons-Read M. 2014. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. J Am Med Assoc Psychiatry 71:158–165.
  • Coelho R, Viola TW, Walss-Bass C, Brietzke E, Grassi-Oliveira R. 2014. Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr Scand 129:180–192.
  • Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT. 2007. Social regulation of gene expression in human leukocytes. Genome Biol 8:R189.
  • Courtet P, Gottesman, II, Jollant F, Gould, TD. 2011. The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies? Transl Psychiatry 1, pii:e7.
  • Courtet P. 2013. Suicide et environnement social. Paris: DUNOD.
  • Couzin-Frankel J. 2010. Inflammation bares a dark side. Science 330:1621.
  • Danese A, McEwen BS. 2012. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav 106:29–39.
  • Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A. 2008. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65:409–415.
  • Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 321:199–204.
  • Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56.
  • DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. 2010. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 71:1605–1611.
  • Dich N, Hansen AM, Avlund K, Lund R, Mortensen EL, Bruunsgaard H, et al. 2014. Early life adversity potentiates the effects of later life stress on cumulative physiological dysregulation. Anxiety Stress Coping 1–19.
  • Dickerson SS, Gable SL, Irwin MR, Aziz N, Kemeny ME. 2009. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Psychol Sci 20:1237–1244.
  • Dietz LJ, Stoyak S, Melhem N, Porta G, Matthews KA, Walker Payne M, et al. 2013. Cortisol response to social stress in parentally bereaved youth. Biol Psychiatry 73:379–387.
  • Dong H, Zhang X, Dai X, Lu S, Gui B, Jin, W, et al. 2014. Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway. J Neuroinflammation 11:140.
  • Dowlati Y, Herrmann N, Swardfager, W, Liu H, Sham L, Reim EK, et al. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457.
  • Ducasse D, Olié E, Guillaume S, Artero S, Courtet P. 2015. A meta-analysis of cytokines in suicidal beahvior. Brain Behav Immun 46:203–211.
  • Ducasse D, Rene E, Beziat S, Guillaume S, Courtet P, Olie E. 2014. Acceptance and commitment therapy for management of suicidal patients: a pilot study. Psychother Psychosom 83:374–376.
  • Eisenberger NI. 2012. The pain of social disconnection: examining the shared neural underpinnings of physical and social pain. Nat Rev Neurosci 13:421–434.
  • Eisenberger NI, Lieberman MD. 2004. Why rejection hurts: a common neural alarm system for physical and social pain. Trends Cogn Sci 8:294–300.
  • Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D, Samuelsson M, et al. 2013. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743–752.
  • Falcone T, Fazio V, Lee C, Simon B, Franco K, Marchi N, et al. 2010. Serum SB100: a potential biomarker for suicidality in adolescents? PloS One 5:e11089.
  • Fardet L, Petersen I, Nazareth I. 2012. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169:491–497.
  • Feinstein A. 2002. An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674–678.
  • Feinstein A. 2011. Multiple sclerosis and depression. Mult Scler 17:1276–1281.
  • Felger JC, Lotrich FE. 2013. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199–229.
  • Fragoso YD, Frota ER, Lopes JS, Noal JS, Giacomo MC, Gomes S, et al. 2010. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 33:312–316.
  • Fredrikson S, Cheng Q, Jiang G, Wasserman D. 2003. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 22:146–152.
  • Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H, Ueshima T, et al. 1998. Burns in a suicide attempt related to psychiatric side effects of interferon. Burns 24:581–583.
  • Gabbay V, Klein RG, Guttman LE, Babb JS, Alonso CM, Nishawala M, et al. 2009. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol 19:423–430.
  • Galfalvy H, Mann JJ. 2011. Cerebrospinal fluid biomarkers in suicide attempters. Acta Psychiatr Scand 124:4–5.
  • Gettings L. 2010. Psychological well-being in rheumatoid arthritis: a review of the literature. Musculoskeletal Care 8:99–106.
  • Goodin DS, Corwin M, Kaufman D, Golub H, Reshef S, Rametta MJ, et al. 2014. Causes of death among commercially insured multiple sclerosis patients in the United States. PloS One 9:e105207.
  • Goodwin RD, Eaton, WW. 2005. Asthma, suicidal ideation, and suicide attempts: findings from the Baltimore epidemiologic catchment area follow-up. Am J Public Health 95:717–722.
  • Goodwin RD, Messineo K, Bregante A, Hoven CW, Kairam R. 2005. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma 42:643–647.
  • Grassi-Oliveira R, Brieztke E, Teixeira A, Pezzi JC, Zanini M, Lopes RP, et al. 2012. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Rev Bras Psiquiatr 34:71–75.
  • Greden JF. 2001. The burden of disease for treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):26–31.
  • Hackett RA, Hamer M, Endrighi R, Brydon L, Steptoe A. 2012. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology 37:1801–1809.
  • Hanke ML, Kielian T. 2011. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (London) 121:367–387.
  • Haroon E, Raison CL, Miller AH. 2012. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137–162.
  • Harris EC, Barraclough BM. 1994. Suicide as an outcome for medical disorders. Medicine (Baltimore) 73:281–296.
  • Henningsson S, Baghaei F, Rosmond R, Holm G, Landen M, Anckarsater H, et al. 2008. Association between serum levels of C-reactive protein and personality traits in women. Behav Brain Funct 4:16.
  • Holsboer F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501.
  • Hsu PC, Groer M, Beckie T. 2014. New findings: Depression, suicide, and Toxoplasma gondii infection. J Am Assoc Nurse Pract 26:629–637.
  • Huang TL, Lee CT. 2007. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 61:415–420.
  • Irwin MR, Cole SW. 2011. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 11: 625–632.
  • Isometsa E, Heikkinen M, Henriksson M, Aro H, Lonnqvist J. 1995. Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides . J Affect Disord 33:99–106.
  • Isung J, Aeinehband S, Mobarrez F, Martensson B, Nordstrom P, Asberg M, et al. 2012a. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2, e196.
  • Isung J, Mobarrez F, Nordstrom P, Asberg M, Jokinen J. 2012b. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry 13:468–473.
  • Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. 2011. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25:335–339.
  • Janelidze S, Ventorp F, Erhardt S, Hansson O, Minthon L, Flax J, et al. 2013. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology 38:853–862.
  • Janelidze S, Suchankova P, Ekman A, Erhardt S, Sellgren C, Samuelsson M, et al. 2014. Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels. Acta Psychiatr Scand 1–10.
  • Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. 1994. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 21:241–243.
  • Joiner T. 2005. Why people die by suicide. Cambridge, MA: Harvard University Press.
  • Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, et al. 2011. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry 165:740–748.
  • Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D. 2012. Serum concentrations of CRP, IL6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res 198:74–80.
  • Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, et al. 2008. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:356–361.
  • Knox KL, Litts DA, Talcott GW, Feig JC, Caine ED. 2003. Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: cohort study. Br Med J 327:1376.
  • Kodaka M, Matsumoto T, Katsumata Y, Akazawa M, Tachimori H, Kawakami N, et al. 2014. Suicide risk among individuals with sleep disturbances in Japan: a case-control psychological autopsy study. Sleep Med 15:430–435.
  • Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. 2003. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 64:708–714.
  • Kudoh A, Takahira Y, Katagai H, Takazawa T. 2002. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95:114–118, table of contents.
  • Labonte B, Yerko V, Gross J, Mechawar N, Meaney MJ, Szyf M, et al. 2012. Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry 72:41–48.
  • Lana-Peixoto MA, Teixeira AL Jr, Haase VG. 2002. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis. Arq Neuropsiquiatr 60:721–724.
  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379.
  • Larkin GL, Beautrais AL. 2011. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14:1127–1131.
  • Lee HY, Kim YK. 2010. Transforming growth factor-beta1 and major depressive disorder with and without attempted suicide: preliminary study. Psychiatry Res 178:92–96.
  • Leonard B 2000. Stress, depression and the activation of the immune system. World J Biol Psychiatry 1:17–25.
  • Lester D. 1992. The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry 25: 265–270.
  • Li H, Li Q, Du X, Sun Y, Wang X, Kroemer G, et al. 2011. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 31:2106–2115.
  • Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, et al. 2013. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-alpha) in the Chinese patients with major depressive disorder: a prospective longitudinal study. Psychoneuroendocrinology 38:107–114.
  • Lindqvist D, Janelidze S, Erhardt S, Traskman-Bendz L, Engstrom G, Brundin L. 2011. CSF biomarkers in suicide attempters–a principal component analysis. Acta Psychiatr Scand 124:52–61.
  • Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, et al. 2009. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66:287–292.
  • Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. 2011. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 199:440–444.
  • Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG. 2010. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol 33:191–197.
  • Matsukawa Y, Sawada S, Hayama T, Usui H, Horie T. 1994. Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3:31–35.
  • McGirr A, Diaconu G, Berlim MT, Pruessner JC, Sable R, Cabot S, et al. 2010. Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci 35:399–408.
  • McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonte B, Szyf M, et al. 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348.
  • McNally L, Bhagwagar Z, Hannestad J. 2008. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 13:501–510.
  • Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. 2004. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683.
  • Mendlovic S, Mozes E, Eilat E, Doron A, Lereya J, Zakuth V, et al. 1999. Immune activation in non-treated suicidal major depression. Immunol Lett 67:105–108.
  • Miller GE, Chen E, Parker KJ. 2011. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull 137:959–997.
  • Mitchell AM, Possel P, Sjogren E, Kristenson M. 2013. Hopelessness the “active ingredient”? Associations of hopelessness and depressive symptoms with interleukin-6. Int J Psychiatry Med 46:109–117.
  • Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. 2013. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74:15–25.
  • Mok CC, Chan KL, Cheung EF, Yip PS. 2014. Suicidal ideation in patients with systemic lupus erythematosus: incidence and risk factors. Rheumatology (Oxford) 53:714–721.
  • Monfrim X, Gazal M, De Leon PB, Quevedo L, Souza LD. 2014. Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1b? Bipolar Disord 16: 741–747.
  • Motivala SJ, Sarfatti A, Olmos L, Irwin MR. 2005. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67:187–194.
  • Muller N, Schwartz MJ. 2007. The immune-mediated alteration of serotonin and glutamate: towards and integrated view of depression. Mol Psychiatry 12:988–1000.
  • Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. 2009.
  • Cadiovascular, inflammatory and metabolic consequences of sleep deprivation. Progr Cardiovasc Dis 51:294–302.
  • Murphy ML, Slavich GM, Rohleder N, Miller GE. 2013. Targeted rejection triggers differential pro- and anti-inflammatory gene expression in adolescents as a function of social status. Clin Psychol Sci 1:30–40.
  • Nowak G, Ordway GA, Paul IA. 1995. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157–164.
  • O’Donovan A, Lin J, Tillie J, Dhabhar FS, Wolkowitz OM, Blackburn EH, et al. 2009. Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav Immun 23:446–449.
  • O’Donovan A, Rush G, Hoatam G, Hughes BM, McCrohan A, Kelleher C, et al. 2013. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anx 30:307–314.
  • Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, et al. 2011. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133:150–155.
  • Okusaga O, Postolache TT. 2012. Toxoplasma gondii, the immune system, and suicidal behavior. In: Dwivedi Y, editor. Source. The Neurobiological Basis of Suicide. Boca Raton, FL: CRC Press. Chapter 19. Frontiers in neuroscience.
  • Omrani MD, Bagheri M, Bushehri B, Azizi F, Anoshae MR. 2012. The association of TGF-beta1 codon 10 polymorphism with suicide behavior. Am J Med Genet B Neuropsychiatr Genet 159B:772–775.
  • Omrani MD, Bushehri B, Bagheri M, Salaki-Lak S, Alipour A, Anoshae MR, et al. 2009. Role of IL-10 -1082, IFN-gamma + 874, and TNF-alpha -308 genes polymorphisms in suicidal behavior. Arch Suicide Res 13:330–339.
  • Opp MR, Born J, Irwin MR. 2007. Sleep and the immune system. In: Ader R, editor. Psychoneuroimmunology. New York, NY: Academic Press. p 570–618.
  • Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF, Burke A, et al. 2004. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 161:1433–1441.
  • Pace TW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD, et al. 2009. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 34:87–98.
  • Pandey GN, Rizavi HS, Ren X, Bhaumik R, Dwivedi Y. 2014. Toll-like receptors in the depressed and suicide brain. J Psychiatr Res 53:62–68.
  • Pandey GN, Rizavi HS, Ren X, Dwivedi Y, Palkovits M. 2013. Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims. Psychoneuroendocrinology 38:2628–2639.
  • Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, et al. 2012. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 46:57–63.
  • Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. 2012. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 69: 1123–1130.
  • Perez-Ortiz JM, Garcia-Gutierrez MS, Navarrete F, Giner S, Manzanares J. 2013. Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 38:1251–1258.
  • Perroud N, Baud P, Ardu S, Krejci I, Mouthon D, Vessaz M, et al. 2013. Temperament personality profiles in suicidal behaviour: an investigation of associated demographic, clinical and genetic factors. J Affect Disord 146:246–253.
  • Perroud N, Baud P, Mouthon D, Courtet P, Malafosse A. 2011. Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders. J Affect Disord 134:112–118.
  • Perroud N, Courtet P, Vincze I, Jaussent I, Jollant F, Bellivier F, et al. 2008. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav 7:314–322.
  • Pinho de Oliveira Ribeiro N, Rafael de Mello Schier A, Ornelas AC, Pinho de Oliveira CM, Nardi AE, Silva AC. 2013. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry 54:1185–1189.
  • Postolache TT, Mortensen PB, Tonelli LH, Jiao X, Frangakis C, Soriano JJ, et al. 2010. Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders. J Affect Disord 121:88–93.
  • Postolache TT, Stiller JW, Herrell R, Goldstein MA, Shreeram SS, Zebrak R, et al. 2005. Tree pollen peaks are associated with increased nonviolent suicide in women. Mol Psychiatry 10: 232–235.
  • Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. 2008. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808.
  • Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, et al. 2014. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anx 31:335–343.
  • Price RB, Nock MK, Charney DS, Mathew SJ. 2009. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66:522–526.
  • Qin P, Mortensen PB, Waltoft BL, Postolache TT. 2011. Allergy is associated with suicide completion with a possible mediating role of mood disorder – a population-based study. Allergy 66:658–664.
  • Raison CL, Miller AH. 2003. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160:1554–1565.
  • Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. 2013. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment- resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31–41.
  • Ribeiro JD, Joiner TE. 2009. The interpersonal-psychological theory of suicidal behavior: current status and future directions. J Clin Psychol 65:1291–1299.
  • Roy B, Diez-Roux AV, Seeman T, Ranjit N, Shea S, Cushman M. 2010. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med 72:134–140.
  • Rujescu D, Giegling I. 2010. The genetics of neurosystems in mental ill-health and suicidality: beyond serotonin. Eur Psychiatry 25:272–274.
  • Sadovnick AD, Eisen K, Ebers GC, Paty DW. 1991. Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196.
  • Saiz PA, Garcia-Portilla P, Paredes B, Arango C, Morales B, Alvarez V, et al. 2008. Association study of the interleukin-1 gene complex and tumor necrosis factor alpha gene with suicide attempts. Psychiatr Genet 18:147–150.
  • Saiz PA, Garcia-Portilla P, Paredes B, Corcoran P, Arango C, Morales B, et al. 2011. Role of serotonergic-related systems in suicidal behavior: data from a case-control association study. Prog Neuropsychopharmacol Biol Psychiatry 35:1518–1524.
  • Schnieder TP, Trencevska I, Rosoklija G, Stankov A, Mann JJ, Smiley J, et al. 2014. Microglia of prefrontal white matter in suicide. J Neuropathol Exp Neurol 73:880–890.
  • Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ. 2010. Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 90: 230–245.
  • Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J, et al. 2012. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PloS One 7, e35367.
  • Slavich GM, Cole SW. 2013. The emerging field of human social genomics. Clin Psychol Sci 1:331–348.
  • Slavich GM, Thornton T, Torres LD, Monroe SM, Gotlib IH. 2009. Targeted rejection predicts hastened onset of major depression. J Soc Clin Psychol 28:223–243.
  • Sockalingam S, Links PS, Abbey SE. 2011. Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update. J Viral Hepat 18:153–160.
  • Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, et al. 2008. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42:151–157.
  • Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein HG, et al. 2006. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112:305–316.
  • Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, et al. 2011. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94.
  • Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K, et al. 1992. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55:542–545.
  • Stuart MJ, Baune BT. 2014. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev 42:93–115.
  • Suarez EC. 2008. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 22:960–968.
  • Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. 2011. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 25:1272–1278.
  • Suchankova P, Henningsson S, Baghaei F, Rosmond R, Holm G, Ekman A. 2009. Genetic variability within the innate immune system influences personality traits in women. Genes Brain Behav 8:212–217.
  • Suchankova P, Holm G, Traskman-Bendz L, Brundin L, Ekman A. 2013. The + 1444C> T polymorphism in the CRP gene: a study on personality traits and suicidal behaviour. Psychiatr Genet 23:70–76.
  • Sutin AR, Terracciano A, Deiana B, Naitza S, Ferrucci L, Uda M, et al. 2010. High neuroticism and low conscientiousness are associated with interleukin-6. Psychol Med 40:1485–1493.
  • Thakurta RG, Das R, Bhattacharya AK, Saha D, Sen S, Singh OP, et al. 2012. Rapid response with ketamine on suicidal cognition in resistant depression. Indian J Psychol Med 34:170–175.
  • Tiihonen J, Virkkunen M, Rasanen P, Pennanen S, Sainio EL, Callaway J, et al. 2001. Free L-tryptophan plasma levels in antisocial violent offenders. Psychopharmacology (Berlin) 157:395–400.
  • Timonen M, Viilo K, Hakko H, Sarkioja T, Meyer-Rochow VB, Vaisanen E, et al. 2004. Is seasonality of suicides stronger in victims with hospital-treated atopic disorders? Psychiatry Res 126:167–175.
  • Timonen M, Viilo K, Hakko H, Sarkioja T, Ylikulju M, Meyer-Rochow VB, et al. 2003. Suicides in persons suffering from rheumatoid arthritis. Rheumatology (Oxford) 42:287–291.
  • Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, et al. 2008. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 117:198–206.
  • Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N. 2014. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50–59.
  • Torres-Platas SG, Hercher C, Davoli MA, Maussion G, Labonte B, Turecki G, et al. 2011. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 36:2650–2658.
  • Treharne GJ, Lyons AC, Kitas GD. 2000. Suicidal ideation in patients with rheumatoid arthritis. Research may help identify patients at high risk. Br Med J 321:1290.
  • Turiano NA, Mroczek DK, Moynihan J, Chapman BP. 2013. Big 5 personality traits and interleukin-6: evidence for “healthy Neuroticism” in a US population sample. Brain Behav Immun 28:83–89.
  • Turner AP, Williams RM, Bowen JD, Rivlahan DR, Haselkorn JK. 2006. Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil 87:1073–1078.
  • Tursich M, Neufeld RW, Frewen PA, Harricharan S, Kibler JL, Rhind SG, et al. 2014. Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis. Transl Psychiatry 4, e413.
  • Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL. 2013. The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatr Scand 128:434–447.
  • Uher R, Tansey KE, Dew T, Maier, W, Mors O, Hauser J, et al. 2014. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry.
  • Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C, et al. 2006. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ 332:1241–1245.
  • Valkanova V, Ebmeier KP, Allan CL. 2013. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150:736–744.
  • Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE. 2010. The interpersonal theory of suicide. Psychol Rev 117:575–600.
  • Vargas HO, Nunes SO, Pizzo de Castro M, Bortolasci CC, Sabbatini Barbosa D, Kaminami Morimoto H, et al. 2013. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 150:923–930.
  • Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, et al. 1999. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603–2607.
  • Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. 2004. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119–2126.
  • Vignau J, Soichot M, Imbenotte M, Jacquemont MC, Danel T, Vandamme M, et al. 2010. Impact of tryptophan metabolism on the vulnerability to alcohol-related blackouts and violent impulsive behaviours. Alcohol Alcohol 45:79–88.
  • Viner R, Patten SB, Berzins S, Bulloch AG, Fiest KM. 2014. Prevalence and risk factors for suicidal ideation in a multiple sclerosis population. J Psychosom Res 76:312–316.
  • Williams KD. 2007. Ostracism. Annu Rev Psychol 58:425–452.
  • Woo JM, Gibbons RD, Qin P, Komarow H, Kim JB, Rogers CA, et al. 2011. Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis: an ecological study. J Clin Psychiatry 72:1423–1428.
  • Woo JM, Okusaga O, Postolache TT. 2012. Seasonality of suicidal behavior. Int J Environ Res Public Health 9:531–547.
  • Xie LF, Chen PL, Pan HF, Tao JH, Li XP, Zhang YJ, et al. 2012. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int 32: 2707–2714.
  • Yagmur F, Yazar S, Temel HO, Cavusoglu M. 2010. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 199:15–17.
  • Yamakawa K, Matsunaga M, Isowa T, Kimura K, Kasugai K, Yoneda M, et al. 2009. Transient responses of inflammatory cytokines in acute stress. Biol Psychol 82:25–32.
  • Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K. 2015. Serum Interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 77:e19–20.
  • Yirmiya R, Goshen I. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181–213.
  • Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, et al. 2012. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71: 939–946.
  • Zhang Y, Traskman-Bendz L, Janelidze S, Langenberg P, Saleh A, Constantine N, et al. 2012. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 73:1069–1076.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.